205 related articles for article (PubMed ID: 3930103)
1. Screening test for urinary glycosaminoglycans and differentiation of various mucopolysaccharidoses.
Huang KC; Sukegawa K; Orii T
Clin Chim Acta; 1985 Sep; 151(2):147-56. PubMed ID: 3930103
[TBL] [Abstract][Full Text] [Related]
2. Separation of sulfated urinary glycosaminoglycans by high-resolution electrophoresis for isotyping of mucopolysaccharidoses in Malaysia.
Nor A; Zabedah MY; Norsiah MD; Ngu LH; Suhaila AR
Malays J Pathol; 2010 Jun; 32(1):35-42. PubMed ID: 20614724
[TBL] [Abstract][Full Text] [Related]
3. MPS screening methods, the Berry spot and acid turbidity tests, cause a high incidence of false-negative results in sanfilippo and morquio syndromes.
Chih-Kuang C; Shuan-Pei L; Shyue-Jye L; Tuen-Jen W
J Clin Lab Anal; 2002; 16(5):253-8. PubMed ID: 12357455
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
[TBL] [Abstract][Full Text] [Related]
5. Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses.
de Jong JG; Wevers RA; Laarakkers C; Poorthuis BJ
Clin Chem; 1989 Jul; 35(7):1472-7. PubMed ID: 2503262
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis.
Chuang CK; Lin SP; Chung SF
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):15-22. PubMed ID: 11310367
[TBL] [Abstract][Full Text] [Related]
7. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Zhang H; Wood T; Young SP; Millington DS
Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses: an evaluation.
Gray G; Claridge P; Jenkinson L; Green A
Ann Clin Biochem; 2007 Jul; 44(Pt 4):360-3. PubMed ID: 17594782
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of urinary glycosaminoglycans assay for a mucopolysaccharidosis-specific screening.
Sabir ES; Lafhal K; Ezoubeiri A; Harkati I; Sbyea S; Aldámiz-Echevarría L; Andrade F; Ait Babram M; Maoulainine FMR; Draiss G; Rada N; Bouskraoui M; Karim A; Fdil N
Pediatr Int; 2020 Sep; 62(9):1077-1085. PubMed ID: 32357280
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of mucopolysaccharidoses in a clinically selected population by urinary glycosaminoglycan analysis: a study of 2,000 urine samples.
Piraud M; Boyer S; Mathieu M; Maire I
Clin Chim Acta; 1993 Nov; 221(1-2):171-81. PubMed ID: 8149634
[TBL] [Abstract][Full Text] [Related]
11. A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses.
Langereis EJ; Wagemans T; Kulik W; Lefeber DJ; van Lenthe H; Oussoren E; van der Ploeg AT; Ruijter GJ; Wevers RA; Wijburg FA; van Vlies N
PLoS One; 2015; 10(9):e0138622. PubMed ID: 26406883
[TBL] [Abstract][Full Text] [Related]
12. A selective screening program for the early detection of mucopolysaccharidosis: Results of the FIND project - a 2-year follow-up study.
Colón C; Alvarez JV; Castaño C; Gutierrez-Solana LG; Marquez AM; O'Callaghan M; Sánchez-Valverde F; Yeste C; Couce ML
Medicine (Baltimore); 2017 May; 96(19):e6887. PubMed ID: 28489793
[TBL] [Abstract][Full Text] [Related]
13. Interference of an algal nutritional supplement with a urinary metabolic screening test for glycosaminoglycans in a dog suspected to have a storage disease.
Sewell AC; Pankraz A
Vet Clin Pathol; 2013 Dec; 42(4):504-7. PubMed ID: 24320782
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
[TBL] [Abstract][Full Text] [Related]
15. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS.
Byers S; Rozaklis T; Brumfield LK; Ranieri E; Hopwood JJ
Mol Genet Metab; 1998 Dec; 65(4):282-90. PubMed ID: 9889015
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of intracellular and excretory glycosaminoglycans in hereditary mucopolysaccharidoses].
Odinokova ON; Bialik MA; Krasnopol'skaia KD; Iakovlev SA
Vopr Med Khim; 1986; 32(1):87-92. PubMed ID: 3082072
[TBL] [Abstract][Full Text] [Related]
17. The spot test is not a reliable screening procedure for mucopolysaccharidoses.
de Jong JG; Hasselman JJ; van Landeghem AA; Vader HL; Wevers RA
Clin Chem; 1991 Apr; 37(4):572-5. PubMed ID: 1901775
[TBL] [Abstract][Full Text] [Related]
18. UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses.
Auray-Blais C; Lavoie P; Tomatsu S; Valayannopoulos V; Mitchell JJ; Raiman J; Beaudoin M; Maranda B; Clarke JT
Anal Chim Acta; 2016 Sep; 936():139-48. PubMed ID: 27566349
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of mucopolysaccharidoses: how to avoid false positives and false negatives.
Mahalingam K; Janani S; Priya S; Elango EM; Sundari RM
Indian J Pediatr; 2004 Jan; 71(1):29-32. PubMed ID: 14979382
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests.
Mabe P; Valiente A; Soto V; Cornejo V; Raimann E
Clin Chim Acta; 2004 Jul; 345(1-2):135-40. PubMed ID: 15193988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
